Notably, the PNPLA3 (Palatin-like phospholipase domain-containing 3) gene is the predominant genetic factor influencing the onset and progression of NAFLD to NASH fibrosis and potentially HCC [54]. Here, PNPLA3 is linked to metabolic dysfunction-associated steatohepatitis.